Breast cancer resistance protein (BCRP/ABCG2) localises to the nucleus in glioblastoma multiforme cells

The choreography of multidrug export: Figure 1

(2015) Rupak Doshi et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Phosphorylation meets nuclear import: a review

(2012) Jonathan D Nardozzi et al.   Cell Communication and Signaling

The ABCG2 resistance network of glioblastoma

(2011) Anne-Marie Bleau et al.   CELL CYCLE

Multidrug Efflux Pumps and Cancer Stem Cells: Insights Into Multidrug Resistance and Therapeutic Development

(2011) K Moitra et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Structure and Function of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)

(2010) Zhanglin Ni et al.   CURRENT DRUG METABOLISM

The role of human ABC transporter ABCG2 (BCRP) in pharmacotherapy

(2009) Toshihisa Ishikawa   ADVANCED DRUG DELIVERY REVIEWS

Impact of cellular folate status and epidermal growth factor receptor expression on BCRP/ABCG2-mediated resistance to gefitinib and erlotinib

(2009) C Lemos et al.   BRITISH JOURNAL OF CANCER

Mitochondrial Expression and Functional Activity of Breast Cancer Resistance Protein in Different Multiple Drug-Resistant Cell Lines

(2009) M. Solazzo et al.   CANCER RESEARCH

Tie2-mediated multidrug resistance in malignant gliomas is associated with upregulation of ABC transporters

(2009) V Martin et al.   ONCOGENE

ABCG2: A perspective

(2008) Robert W. Robey et al.   ADVANCED DRUG DELIVERY REVIEWS

Insights into signaling from the β2-adrenergic receptor structure

(2008) Martin Audet et al.   Nature Chemical Biology

Expression and localisation of breast cancer resistance protein (BCRP) in human fetal membranes and decidua and the influence of labour at term

(2008) D. Yeboah et al.   REPRODUCTION FERTILITY AND DEVELOPMENT